Loading…
Reported covered position: Administrator & Consultant, CMS; Dep. Asst. to President; Counselor to the Dir., Dir. for Hum. Res. Vets and Labor; Associate Dir. for Legislative Affairs, OMB
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Issues related to drug pricing S.2543 - Prescription Drug Pricing Reduction Act of 2019 H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act Outreach regarding Rare Disease and Part-D copay assistance report language in FY2021 Labor HHS Appropriations cycle Outreach regarding drug supply concerns. COVID relief proposals Outreach on biosimilar shared savings.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
UPMC HEALTH PLAN via LINCOLN POLICY GROUP
2021 · third_quarter · 3T
Issues related to COVID; General issues related to Medicare and Medicaid; issues related to commercial insurance
Issues related to COVID; General issues related to Medicare and Medicaid; issues related to commercial insurance
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Source: Senate LDA
| KIDNEY CARE COUNCIL |
| 9 |
| 2017–2019 |
| AETNA, INC. | 7 | 2017–2019 |
| UPMC HEALTH PLAN | 7 | 2020–2021 |
| VERAX BIOMEDICAL | 5 | 2017–2018 |
| BUCHANAN, INGERSOLL, & ROONEY OBO STRATEGIC HEALTH INFO EXCHANGE COLLABORATIVE | 3 | 2020 |
| MATRIX MEDICAL NETWORK | 1 | 2017 |
Issues related to drug pricing S.2543 - Prescription Drug Pricing Reduction Act of 2019 H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act Outreach regarding Rare Disease and Part-D copay assistance report language in FY2021 Labor HHS Appropriations cycle Outreach regarding drug supply concerns. COVID relief proposals Outreach on biosimilar shared savings.
Issues related to drug pricing S.2543 - Prescription Drug Pricing Reduction Act of 2019 H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act Outreach regarding Rare Disease and Part-D copay assistance report language in FY2021 Labor HHS Appropriations cycle Outreach regarding drug supply concerns. COVID relief proposals Outreach on biosimilar shared savings.
Community-Based Independence for Seniors Act of 2019
Client: SCAN HEALTH PLAN · Firm: LINCOLN POLICY GROUP
Medicare Advantage and SNP plans; Issues related to dual eligibles. H.R. 3461 Community-Based Independence for Seniors Act of 2019
Community-Based Independence for Seniors Act of 2019
Client: SCAN HEALTH PLAN · Firm: LINCOLN POLICY GROUP
Medicare Advantage and SNP plans; issues related to dual eligibles. H.R. 3461 Community-Based Independence for Seniors Act of 2019
Community-Based Independence for Seniors Act of 2019
Client: SCAN HEALTH PLAN · Firm: LINCOLN POLICY GROUP
Medicare Advantage and SNP plans; issues related to dual eligibles. H.R. 3461 Community-Based Independence for Seniors Act of 2019
Community-Based Independence for Seniors Act of 2019
Client: SCAN HEALTH PLAN · Firm: LINCOLN POLICY GROUP
Medicare Advantage and SNP plans; Issues related to dual eligibles. H.R. 3461 Community-Based Independence for Seniors Act of 2019
Community-Based Independence for Seniors Act of 2019
Client: SCAN HEALTH PLAN · Firm: LINCOLN POLICY GROUP
Medicare Advantage and SNP plans; issues related to dual eligibles. H.R. 3461 Community-Based Independence for Seniors Act of 2019
Community-Based Independence for Seniors Act of 2019
Client: SCAN HEALTH PLAN · Firm: LINCOLN POLICY GROUP
Medicare Advantage and SNP plans; Issues related to dual eligibles. H.R. 3461 Community-Based Independence for Seniors Act of 2019
Medical billing issues Medicare legislative and regulatory issues S.1895 - Lower Health Care Costs Act H.R.3630 - No Surprises Act COVID relief proposals
Medical billing issues Medicare legislative and regulatory issues S.1895 - Lower Health Care Costs Act H.R.3630 - No Surprises Act COVID relief proposals
Medical billing issues Medicare legislative and regulatory issues S.1895 - Lower Health Care Costs Act COVID relief proposals Issues related to No Surprises Act implementation
Medical billing issues Medicare legislative and regulatory issues S.1895 - Lower Health Care Costs Act COVID relief proposals Issues related to No Surprises Act implementation
Prescription Drug Pricing Reduction Act of 2019
Client: AMERISOURCEBERGEN CORPORATION · Firm: LINCOLN POLICY GROUP
General healthcare issues S. 2543--Prescription Drug Pricing Reduction Act of 2019 COVID relief proposals
Prescription Drug Pricing Reduction Act of 2019
Client: AMERISOURCEBERGEN CORPORATION · Firm: LINCOLN POLICY GROUP
General healthcare issues S. 2543--Prescription Drug Pricing Reduction Act of 2019 COVID relief proposals
Issues related to drug pricing S.2543 - Prescription Drug Pricing Reduction Act of 2019 H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act Outreach regarding Rare Disease and Part-D copay assistance report language in FY2021 Labor HHS Appropriations cycle Outreach regarding drug supply concerns. COVID relief proposals Outreach on biosimilar shared savings.
Issues related to drug pricing S.2543 - Prescription Drug Pricing Reduction Act of 2019 H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act Outreach regarding Rare Disease and Part-D copay assistance report language in FY2021 Labor HHS Appropriations cycle Outreach regarding drug supply concerns. COVID relief proposals Outreach on biosimilar shared savings.
Prescription Drug Pricing Reduction Act of 2019
Client: AMERISOURCEBERGEN CORPORATION · Firm: LINCOLN POLICY GROUP
General healthcare issues S. 2543--Prescription Drug Pricing Reduction Act of 2019 COVID relief proposals
Issues related to drug pricing S.2543 - Prescription Drug Pricing Reduction Act of 2019 H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act Outreach regarding Rare Disease and Part-D copay assistance report language in FY2021 Labor HHS Appropriations cycle Outreach regarding drug supply concerns. COVID relief proposals Outreach on biosimilar shared savings.
Dialysis PATIENTS Demonstration Act of 2017
Client: FRESENIUS MEDICAL CARE NORTH AMERICA · Firm: LINCOLN POLICY GROUP
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities. COVID relief proposals Issues relating to Medicare Advantage proposed dialysis access policies
Dialysis PATIENTS Demonstration Act of 2017
Client: FRESENIUS MEDICAL CARE NORTH AMERICA · Firm: LINCOLN POLICY GROUP
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities. COVID relief proposals Issues relating to Medicare Advantage proposed dialysis access policies
Dialysis PATIENTS Demonstration Act of 2017
Client: FRESENIUS MEDICAL CARE NORTH AMERICA · Firm: LINCOLN POLICY GROUP
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities. COVID relief proposals Issues relating to Medicare Advantage proposed dialysis access policies
Dialysis PATIENTS Demonstration Act of 2017
Client: FRESENIUS MEDICAL CARE NORTH AMERICA · Firm: LINCOLN POLICY GROUP
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities. COVID relief proposals Issues relating to Medicare Advantage proposed dialysis access policies
Paycheck Protection Program and Health Care Enhancement Act
Client: AMERISOURCEBERGEN CORPORATION · Firm: LINCOLN POLICY GROUP
General healthcare issues S. 2543--Prescription Drug Pricing Reduction Act of 2019 Paycheck Protection Program and Healthcare Enhancement Act (CARES Act 2.0) (H.R. 266)
Paycheck Protection Program and Health Care Enhancement Act
Client: UPMC · Firm: LINCOLN POLICY GROUP
Medical billing issues Medicare legislative and regulatory issues S.1895 - Lower Health Care Costs Act H.R.3630 - No Surprises Act Paycheck Protection Program and Healthcare Enhancement Act (CARES Act 2.0) (H.R. 266)
Paycheck Protection Program and Health Care Enhancement Act
Client: PFIZER · Firm: LINCOLN POLICY GROUP
Issues related to drug pricing S.2543 - Prescription Drug Pricing Reduction Act of 2019 H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act Outreach regarding Rare Disease and Part-D copay assistance report language in FY2021 Labor HHS Appropriations cycle Outreach regarding drug supply concerns. Paycheck Protection Program and Healthcare Enhancement Act (CARES Act 2.0) (H.R. 266) Outreach on biosimilar shared savings.
Paycheck Protection Program and Health Care Enhancement Act
Client: FRESENIUS MEDICAL CARE NORTH AMERICA · Firm: LINCOLN POLICY GROUP
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities. Paycheck Protection Program and Healthcare Enhancement Act (CARES Act 2.0) (H.R. 266) Issues relating to Medicare Advantage proposed dialysis access policies
Paycheck Protection Program and Health Care Enhancement Act
Client: FRESENIUS MEDICAL CARE NORTH AMERICA · Firm: LINCOLN POLICY GROUP
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities. Paycheck Protection Program and Healthcare Enhancement Act (CARES Act 2.0) (H.R. 266) Issues relating to Medicare Advantage proposed dialysis access policies
Issues related to drug pricing S.2543 - Prescription Drug Pricing Reduction Act of 2019 H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act Outreach regarding Rare Disease and Part-D copay assistance report language in FY2021 Labor HHS Appropriations cycle Outreach regarding drug supply concerns. COVID relief proposals Outreach on biosimilar shared savings.
Issues related to drug pricing S.2543 - Prescription Drug Pricing Reduction Act of 2019 H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act Outreach regarding Rare Disease and Part-D copay assistance report language in FY2021 Labor HHS Appropriations cycle Outreach regarding drug supply concerns. Outreach regarding vaccine co-pay language in CARES Act (H.R. 748/S. 3548--Coronavirus Aid, Relief, and Economic Security Act) Outreach on biosimilar shared savings.
Issues related to drug pricing S.2543 - Prescription Drug Pricing Reduction Act of 2019 H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act Outreach regarding Rare Disease and Part-D copay assistance report language in FY2021 Labor HHS Appropriations cycle Outreach regarding drug supply concerns. Paycheck Protection Program and Healthcare Enhancement Act (CARES Act 2.0) (H.R. 266) Outreach on biosimilar shared savings.
Issues related to drug pricing S.2543 - Prescription Drug Pricing Reduction Act of 2019 H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act Outreach regarding Rare Disease and Part-D copay assistance report language in FY2021 Labor HHS Appropriations cycle Outreach regarding drug supply concerns. COVID relief proposals Outreach on biosimilar shared savings.
Community-Based Independence for Seniors Act of 2019
Client: SCAN HEALTH PLAN · Firm: LINCOLN POLICY GROUP
Medicare Advantage and SNP plans; issues related to dual eligibles. H.R. 3461 Community-Based Independence for Seniors Act of 2019
Community-Based Independence for Seniors Act of 2019
Client: SCAN HEALTH PLAN · Firm: LINCOLN POLICY GROUP
Medicare Advantage and SNP plans; Issues related to dual eligibles. H.R. 3461 Community-Based Independence for Seniors Act of 2019
Community-Based Independence for Seniors Act of 2019
Client: SCAN HEALTH PLAN · Firm: LINCOLN POLICY GROUP
Medicare Advantage and SNP plans; issues related to dual eligibles. H.R. 3461 Community-Based Independence for Seniors Act of 2019
Community-Based Independence for Seniors Act of 2019
Client: SCAN HEALTH PLAN · Firm: LINCOLN POLICY GROUP
Medicare Advantage and SNP plans; Issues related to dual eligibles. H.R. 3461 Community-Based Independence for Seniors Act of 2019
Community-Based Independence for Seniors Act of 2019
Client: SCAN HEALTH PLAN · Firm: LINCOLN POLICY GROUP
Medicare Advantage and SNP plans; issues related to dual eligibles. H.R. 3461 Community-Based Independence for Seniors Act of 2019
Community-Based Independence for Seniors Act of 2019
Client: SCAN HEALTH PLAN · Firm: LINCOLN POLICY GROUP
Medicare Advantage and SNP plans; issues related to dual eligibles. H.R. 3461 Community-Based Independence for Seniors Act of 2019
Community-Based Independence for Seniors Act of 2019
Client: SCAN HEALTH PLAN · Firm: LINCOLN POLICY GROUP
Medicare Advantage and SNP plans; Issues related to dual eligibles. H.R. 3461 Community-Based Independence for Seniors Act of 2019
Community-Based Independence for Seniors Act of 2019
Client: SCAN HEALTH PLAN · Firm: LINCOLN POLICY GROUP
Medicare Advantage and SNP plans; Issues related to dual eligibles. H.R. 3461 Community-Based Independence for Seniors Act of 2019
Medical billing issues Medicare legislative and regulatory issues S.1895 - Lower Health Care Costs Act H.R.3630 - No Surprises Act COVID relief proposals
Medical billing issues Medicare legislative and regulatory issues S.1895 - Lower Health Care Costs Act H.R.3630 - No Surprises Act Paycheck Protection Program and Healthcare Enhancement Act (CARES Act 2.0) (H.R. 266)
Medical billing issues Medicare legislative and regulatory issues S.1895 - Lower Health Care Costs Act H.R.3630 - No Surprises Act H.R. 748/S. 3548--CARES Act (Coronavirus Aid, Relief, and Economic Security Act) and covid-19 response
Medical billing issues Medicare legislative and regulatory issues S.1895 - Lower Health Care Costs Act H.R.3630 - No Surprises Act COVID relief proposals
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities. H.R. 748/S. 3548--CARES Act (Coronavirus Aid, Relief, and Economic Security Act) and covid-19 response Issues relating to Medicare Advantage proposed dialysis access policies
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities. H.R. 748/S. 3548--CARES Act (Coronavirus Aid, Relief, and Economic Security Act) and covid-19 response Issues relating to Medicare Advantage proposed dialysis access policies
Medical billing issues Medicare legislative and regulatory issues S.1895 - Lower Health Care Costs Act H.R.3630 - No Surprises Act H.R. 748/S. 3548--CARES Act (Coronavirus Aid, Relief, and Economic Security Act) and covid-19 response
Issues related to drug pricing S.2543 - Prescription Drug Pricing Reduction Act of 2019 H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act Outreach regarding Rare Disease and Part-D copay assistance report language in FY2021 Labor HHS Appropriations cycle Outreach regarding drug supply concerns. Outreach regarding vaccine co-pay language in CARES Act (H.R. 748/S. 3548--Coronavirus Aid, Relief, and Economic Security Act) Outreach on biosimilar shared savings.
General healthcare issues S. 2543--Prescription Drug Pricing Reduction Act of 2019 H.R. 748/S. 3548--CARES Act (Coronavirus Aid, Relief, and Economic Security Act) and covid-19 response
Medical billing issues Medicare legislative and regulatory issues S.1895 - Lower Health Care Costs Act H.R.3630 - No Surprises Act COVID relief proposals
Medical billing issues Medicare legislative and regulatory issues S.1895 - Lower Health Care Costs Act H.R.3630 - No Surprises Act H.R. 748/S. 3548--CARES Act (Coronavirus Aid, Relief, and Economic Security Act) and covid-19 response
Medical billing issues Medicare legislative and regulatory issues S.1895 - Lower Health Care Costs Act H.R.3630 - No Surprises Act COVID relief proposals
Medical billing issues Medicare legislative and regulatory issues S.1895 - Lower Health Care Costs Act H.R.3630 - No Surprises Act Paycheck Protection Program and Healthcare Enhancement Act (CARES Act 2.0) (H.R. 266)
Issues related to drug pricing S.2543 - Prescription Drug Pricing Reduction Act of 2019 H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act Outreach regarding Rare Disease and Part-D copay assistance report language in FY2021 Labor HHS Appropriations cycle Outreach regarding drug supply concerns. COVID relief proposals Outreach on biosimilar shared savings.
Issues related to drug pricing S.2543 - Prescription Drug Pricing Reduction Act of 2019 H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act Outreach regarding Rare Disease and Part-D copay assistance report language in FY2021 Labor HHS Appropriations cycle Outreach regarding drug supply concerns. Paycheck Protection Program and Healthcare Enhancement Act (CARES Act 2.0) (H.R. 266) Outreach on biosimilar shared savings.
Prescription Drug Pricing Reduction Act of 2019
Client: AMERISOURCEBERGEN CORPORATION · Firm: LINCOLN POLICY GROUP
General healthcare issues S. 2543--Prescription Drug Pricing Reduction Act of 2019 COVID relief proposals
Issues related to drug pricing S.2543 - Prescription Drug Pricing Reduction Act of 2019 H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act Outreach regarding Rare Disease and Part-D copay assistance report language in FY2021 Labor HHS Appropriations cycle Outreach regarding drug supply concerns. Outreach regarding vaccine co-pay language in CARES Act (H.R. 748/S. 3548--Coronavirus Aid, Relief, and Economic Security Act) Outreach on biosimilar shared savings.
Prescription Drug Pricing Reduction Act of 2019
Client: AMERISOURCEBERGEN CORPORATION · Firm: LINCOLN POLICY GROUP
General healthcare issues S. 2543--Prescription Drug Pricing Reduction Act of 2019 Paycheck Protection Program and Healthcare Enhancement Act (CARES Act 2.0) (H.R. 266)
Prescription Drug Pricing Reduction Act of 2019
Client: AMERISOURCEBERGEN CORPORATION · Firm: LINCOLN POLICY GROUP
General healthcare issues S. 2543--Prescription Drug Pricing Reduction Act of 2019 COVID relief proposals
Prescription Drug Pricing Reduction Act of 2019
Client: AMERISOURCEBERGEN CORPORATION · Firm: LINCOLN POLICY GROUP
General healthcare issues S. 2543--Prescription Drug Pricing Reduction Act of 2019 H.R. 748/S. 3548--CARES Act (Coronavirus Aid, Relief, and Economic Security Act) and covid-19 response
Issues related to drug pricing S.2543 - Prescription Drug Pricing Reduction Act of 2019 H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act Outreach regarding Rare Disease and Part-D copay assistance report language in FY2021 Labor HHS Appropriations cycle Outreach regarding drug supply concerns. COVID relief proposals Outreach on biosimilar shared savings.
Issues related to drug pricing S.2543 - Prescription Drug Pricing Reduction Act of 2019 H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act Outreach regarding Rare Disease and Part-D copay assistance report language in FY2021 Labor HHS Appropriations cycle Outreach regarding drug supply concerns. Outreach regarding vaccine co-pay language in CARES Act (H.R. 748/S. 3548--Coronavirus Aid, Relief, and Economic Security Act) Outreach on biosimilar shared savings.
General healthcare issues S. 2543--Prescription Drug Pricing Reduction Act of 2019 H.R. 748/S. 3548--CARES Act (Coronavirus Aid, Relief, and Economic Security Act) and covid-19 response
Medical billing issues Medicare legislative and regulatory issues S.1895 - Lower Health Care Costs Act H.R.3630 - No Surprises Act H.R. 748/S. 3548--CARES Act (Coronavirus Aid, Relief, and Economic Security Act) and covid-19 response
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities. H.R. 748/S. 3548--CARES Act (Coronavirus Aid, Relief, and Economic Security Act) and covid-19 response Issues relating to Medicare Advantage proposed dialysis access policies
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities. H.R. 748/S. 3548--CARES Act (Coronavirus Aid, Relief, and Economic Security Act) and covid-19 response Issues relating to Medicare Advantage proposed dialysis access policies
Dialysis PATIENTS Demonstration Act of 2017
Client: FRESENIUS MEDICAL CARE NORTH AMERICA · Firm: LINCOLN POLICY GROUP
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities. H.R. 748/S. 3548--CARES Act (Coronavirus Aid, Relief, and Economic Security Act) and covid-19 response Issues relating to Medicare Advantage proposed dialysis access policies
Dialysis PATIENTS Demonstration Act of 2017
Client: FRESENIUS MEDICAL CARE NORTH AMERICA · Firm: LINCOLN POLICY GROUP
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities. COVID relief proposals Issues relating to Medicare Advantage proposed dialysis access policies
Dialysis PATIENTS Demonstration Act of 2017
Client: FRESENIUS MEDICAL CARE NORTH AMERICA · Firm: LINCOLN POLICY GROUP
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities. H.R. 748/S. 3548--CARES Act (Coronavirus Aid, Relief, and Economic Security Act) and covid-19 response Issues relating to Medicare Advantage proposed dialysis access policies
Dialysis PATIENTS Demonstration Act of 2017
Client: FRESENIUS MEDICAL CARE NORTH AMERICA · Firm: LINCOLN POLICY GROUP
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities. Paycheck Protection Program and Healthcare Enhancement Act (CARES Act 2.0) (H.R. 266) Issues relating to Medicare Advantage proposed dialysis access policies
Dialysis PATIENTS Demonstration Act of 2017
Client: FRESENIUS MEDICAL CARE NORTH AMERICA · Firm: LINCOLN POLICY GROUP
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities. COVID relief proposals Issues relating to Medicare Advantage proposed dialysis access policies
Dialysis PATIENTS Demonstration Act of 2017
Client: FRESENIUS MEDICAL CARE NORTH AMERICA · Firm: LINCOLN POLICY GROUP
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities. Paycheck Protection Program and Healthcare Enhancement Act (CARES Act 2.0) (H.R. 266) Issues relating to Medicare Advantage proposed dialysis access policies
Dialysis PATIENTS Demonstration Act of 2017
Client: FRESENIUS MEDICAL CARE NORTH AMERICA · Firm: LINCOLN POLICY GROUP
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities. COVID relief proposals Issues relating to Medicare Advantage proposed dialysis access policies
Dialysis PATIENTS Demonstration Act of 2017
Client: FRESENIUS MEDICAL CARE NORTH AMERICA · Firm: LINCOLN POLICY GROUP
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities. COVID relief proposals Issues relating to Medicare Advantage proposed dialysis access policies
Dialysis PATIENTS Demonstration Act of 2017
Client: FRESENIUS MEDICAL CARE NORTH AMERICA · Firm: LINCOLN POLICY GROUP
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities. Paycheck Protection Program and Healthcare Enhancement Act (CARES Act 2.0) (H.R. 266) Issues relating to Medicare Advantage proposed dialysis access policies
Dialysis PATIENTS Demonstration Act of 2017
Client: FRESENIUS MEDICAL CARE NORTH AMERICA · Firm: LINCOLN POLICY GROUP
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities. H.R. 748/S. 3548--CARES Act (Coronavirus Aid, Relief, and Economic Security Act) and covid-19 response Issues relating to Medicare Advantage proposed dialysis access policies
Dialysis PATIENTS Demonstration Act of 2017
Client: FRESENIUS MEDICAL CARE NORTH AMERICA · Firm: LINCOLN POLICY GROUP
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities. COVID relief proposals Issues relating to Medicare Advantage proposed dialysis access policies
Dialysis PATIENTS Demonstration Act of 2017
Client: FRESENIUS MEDICAL CARE NORTH AMERICA · Firm: LINCOLN POLICY GROUP
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities. COVID relief proposals Issues relating to Medicare Advantage proposed dialysis access policies
Dialysis PATIENTS Demonstration Act of 2017
Client: FRESENIUS MEDICAL CARE NORTH AMERICA · Firm: LINCOLN POLICY GROUP
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities. H.R. 748/S. 3548--CARES Act (Coronavirus Aid, Relief, and Economic Security Act) and covid-19 response Issues relating to Medicare Advantage proposed dialysis access policies
Dialysis PATIENTS Demonstration Act of 2017
Client: FRESENIUS MEDICAL CARE NORTH AMERICA · Firm: LINCOLN POLICY GROUP
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities. Paycheck Protection Program and Healthcare Enhancement Act (CARES Act 2.0) (H.R. 266) Issues relating to Medicare Advantage proposed dialysis access policies
Dialysis PATIENTS Demonstration Act of 2017
Client: FRESENIUS MEDICAL CARE NORTH AMERICA · Firm: LINCOLN POLICY GROUP
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities. COVID relief proposals Issues relating to Medicare Advantage proposed dialysis access policies
Dialysis PATIENTS Demonstration Act of 2017
Client: FRESENIUS MEDICAL CARE NORTH AMERICA · Firm: LINCOLN POLICY GROUP
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities. COVID relief proposals Issues relating to Medicare Advantage proposed dialysis access policies
Issues related to drug pricing S.2543 - Prescription Drug Pricing Reduction Act of 2019 H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act
Community-Based Independence for Seniors Act of 2019
Client: SCAN HEALTH PLAN · Firm: LINCOLN POLICY GROUP
Medicare Advantage and SNP plans; Issues related to dual eligibles. H.R. 3461 Community-Based Independence for Seniors Act of 2019
Community-Based Independence for Seniors Act of 2019
Client: SCAN HEALTH PLAN · Firm: LINCOLN POLICY GROUP
Medicare Advantage and SNP plans; issues related to dual eligibles. H.R. 3461 Community-Based Independence for Seniors Act of 2019
Community-Based Independence for Seniors Act of 2019
Client: SCAN HEALTH PLAN · Firm: LINCOLN POLICY GROUP
Medicare Advantage and SNP plans; Issues related to dual eligibles. H.R. 3461 Community-Based Independence for Seniors Act of 2019
Community-Based Independence for Seniors Act of 2019
Client: SCAN HEALTH PLAN · Firm: LINCOLN POLICY GROUP
Medicare Advantage and SNP plans; issues related to dual eligibles. H.R. 3461 Community-Based Independence for Seniors Act of 2019
Community-Based Independence for Seniors Act of 2019
Client: SCAN HEALTH PLAN · Firm: LINCOLN POLICY GROUP
Medicare Advantage and SNP plans; Issues related to dual eligibles. H.R. 3461 Community-Based Independence for Seniors Act of 2019
Community-Based Independence for Seniors Act of 2019
Client: SCAN HEALTH PLAN · Firm: LINCOLN POLICY GROUP
Medicare Advantage and SNP plans; issues related to dual eligibles. H.R. 3461 Community-Based Independence for Seniors Act of 2019
Community-Based Independence for Seniors Act of 2019
Client: SCAN HEALTH PLAN · Firm: LINCOLN POLICY GROUP
Medicare Advantage and SNP plans; Issues related to dual eligibles. H.R. 3461 Community-Based Independence for Seniors Act of 2019
Community-Based Independence for Seniors Act of 2019
Client: SCAN HEALTH PLAN · Firm: LINCOLN POLICY GROUP
Medicare Advantage and SNP plans; issues related to dual eligibles. H.R. 3461 Community-Based Independence for Seniors Act of 2019
Medical billing issues Medicare legislative and regulatory issues S.1895 - Lower Health Care Costs Act H.R.3630 - No Surprises Act
Medical billing issues Medicare legislative and regulatory issues S.1895 - Lower Health Care Costs Act H.R.3630 - No Surprises Act
Prescription Drug Pricing Reduction Act of 2019
Client: AMERISOURCEBERGEN CORPORATION · Firm: LINCOLN POLICY GROUP
General healthcare issues S. 2543--Prescription Drug Pricing Reduction Act of 2019
Issues related to drug pricing S.2543 - Prescription Drug Pricing Reduction Act of 2019 H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act
Community-Based Independence for Seniors Act of 2017
Client: SCAN HEALTH PLAN · Firm: LINCOLN POLICY GROUP
Medicare Advantage and SNP plans; Issues related to dual eligibles. S.309/H.R.4006 - Community-Based Independence for Seniors Act of 2017
Community-Based Independence for Seniors Act of 2017
Client: SCAN HEALTH PLAN · Firm: LINCOLN POLICY GROUP
Medicare Advantage and SNP plans; issues related to dual eligibles. S.309/H.R.4006 - Community-Based Independence for Seniors Act of 2017
Community-Based Independence for Seniors Act of 2017
Client: SCAN HEALTH PLAN · Firm: LINCOLN POLICY GROUP
Medicare Advantage and SNP plans; issues related to dual eligibles. S.309/H.R.4006 - Community-Based Independence for Seniors Act of 2017
Community-Based Independence for Seniors Act of 2017
Client: SCAN HEALTH PLAN · Firm: LINCOLN POLICY GROUP
Medicare Advantage and SNP plans; Issues related to dual eligibles. S.309/H.R.4006 - Community-Based Independence for Seniors Act of 2017
Dialysis PATIENTS Demonstration Act of 2017
Client: FRESENIUS MEDICAL CARE NORTH AMERICA · Firm: LINCOLN POLICY GROUP
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities.
2021 · third_quarter · 3T
Medical billing issues Medicare legislative and regulatory issues S.1895 - Lower Health Care Costs Act COVID relief proposals Issues related to No Surprises Act implementation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SCAN HEALTH PLAN via LINCOLN POLICY GROUP
2021 · third_quarter · 3T
Medicare Advantage and SNP plans; issues related to dual eligibles. H.R. 3461 Community-Based Independence for Seniors Act of 2019
Medicare Advantage and SNP plans; Issues related to dual eligibles. H.R. 3461 Community-Based Independence for Seniors Act of 2019
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
PFIZER via LINCOLN POLICY GROUP
2021 · third_quarter · 3T
Issues related to drug pricing S.2543 - Prescription Drug Pricing Reduction Act of 2019 H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act Outreach regarding Rare Disease and Part-D copay assistance report language in FY2021 Labor HHS Appropriations cycle Outreach regarding drug supply concerns. COVID relief proposals Outreach on biosimilar shared savings.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
HUMACYTE, INC. via LINCOLN POLICY GROUP
2021 · third_quarter · 3T
Access to regenerative medical technologies.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS MEDICAL CARE NORTH AMERICA via LINCOLN POLICY GROUP
2021 · third_quarter · 3T
CY 2022 End-Stage Renal Disease (ESRD) Prospective Payment System Proposed Rule COVID relief proposals Issues relating to Medicare Advantage proposed dialysis access policies
CY 2022 End-Stage Renal Disease (ESRD) Prospective Payment System Proposed Rule COVID relief proposals Issues relating to Medicare Advantage proposed dialysis access policies
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
AMERISOURCEBERGEN CORPORATION via LINCOLN POLICY GROUP
2021 · third_quarter · 3T
General healthcare issues S. 2543--Prescription Drug Pricing Reduction Act of 2019 COVID relief proposals
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
UPMC HEALTH PLAN via LINCOLN POLICY GROUP
2021 · second_quarter · Q2
Issues related to COVID; General issues related to Medicare and Medicaid; issues related to commercial insurance
Issues related to COVID; General issues related to Medicare and Medicaid; issues related to commercial insurance
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · second_quarter · Q2
Medical billing issues Medicare legislative and regulatory issues S.1895 - Lower Health Care Costs Act COVID relief proposals Issues related to No Surprises Act implementation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SCAN HEALTH PLAN via LINCOLN POLICY GROUP
2021 · second_quarter · Q2
Medicare Advantage and SNP plans; issues related to dual eligibles. H.R. 3461 Community-Based Independence for Seniors Act of 2019
Medicare Advantage and SNP plans; Issues related to dual eligibles. H.R. 3461 Community-Based Independence for Seniors Act of 2019
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
PFIZER via LINCOLN POLICY GROUP
2021 · second_quarter · Q2
Issues related to drug pricing S.2543 - Prescription Drug Pricing Reduction Act of 2019 H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act Outreach regarding Rare Disease and Part-D copay assistance report language in FY2021 Labor HHS Appropriations cycle Outreach regarding drug supply concerns. COVID relief proposals Outreach on biosimilar shared savings.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
HUMACYTE, INC. via LINCOLN POLICY GROUP
2021 · second_quarter · Q2
Access to regenerative medical technologies.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS MEDICAL CARE NORTH AMERICA via LINCOLN POLICY GROUP
2021 · second_quarter · Q2
CY 2022 End-Stage Renal Disease (ESRD) Prospective Payment System Proposed Rule COVID relief proposals Issues relating to Medicare Advantage proposed dialysis access policies
CY 2022 End-Stage Renal Disease (ESRD) Prospective Payment System Proposed Rule COVID relief proposals Issues relating to Medicare Advantage proposed dialysis access policies
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
AMERISOURCEBERGEN CORPORATION via LINCOLN POLICY GROUP
2021 · second_quarter · Q2
General healthcare issues S. 2543--Prescription Drug Pricing Reduction Act of 2019 COVID relief proposals
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
UPMC HEALTH PLAN via LINCOLN POLICY GROUP
2021 · first_quarter · Q1
Issues related to COVID; General issues related to Medicare and Medicaid; issues related to commercial insurance
Issues related to COVID; General issues related to Medicare and Medicaid; issues related to commercial insurance
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · first_quarter · Q1
Medical billing issues Medicare legislative and regulatory issues S.1895 - Lower Health Care Costs Act H.R.3630 - No Surprises Act COVID relief proposals
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SCAN HEALTH PLAN via LINCOLN POLICY GROUP
2021 · first_quarter · Q1
Medicare Advantage and SNP plans; Issues related to dual eligibles. H.R. 3461 Community-Based Independence for Seniors Act of 2019
Medicare Advantage and SNP plans; issues related to dual eligibles. H.R. 3461 Community-Based Independence for Seniors Act of 2019
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
PFIZER via LINCOLN POLICY GROUP
2021 · first_quarter · Q1
Issues related to drug pricing S.2543 - Prescription Drug Pricing Reduction Act of 2019 H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act Outreach regarding Rare Disease and Part-D copay assistance report language in FY2021 Labor HHS Appropriations cycle Outreach regarding drug supply concerns. COVID relief proposals Outreach on biosimilar shared savings.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
HUMACYTE, INC. via LINCOLN POLICY GROUP
2021 · first_quarter · Q1
Access to regenerative medical technologies.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS MEDICAL CARE NORTH AMERICA via LINCOLN POLICY GROUP
2021 · first_quarter · Q1
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities. COVID relief proposals Issues relating to Medicare Advantage proposed dialysis access policies
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities. COVID relief proposals Issues relating to Medicare Advantage proposed dialysis access policies
AMERISOURCEBERGEN CORPORATION via LINCOLN POLICY GROUP
2021 · first_quarter · Q1
General healthcare issues S. 2543--Prescription Drug Pricing Reduction Act of 2019 COVID relief proposals
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
UPMC HEALTH PLAN via LINCOLN POLICY GROUP
2020 · fourth_quarter · Q4
Issues related to COVID; General issues related to Medicare and Medicaid; issues related to commercial insurance
Issues related to COVID; General issues related to Medicare and Medicaid; issues related to commercial insurance
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Q4
Medical billing issues Medicare legislative and regulatory issues S.1895 - Lower Health Care Costs Act H.R.3630 - No Surprises Act COVID relief proposals
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SCAN HEALTH PLAN via LINCOLN POLICY GROUP
2020 · fourth_quarter · Q4
Medicare Advantage and SNP plans; issues related to dual eligibles. H.R. 3461 Community-Based Independence for Seniors Act of 2019
Medicare Advantage and SNP plans; Issues related to dual eligibles. H.R. 3461 Community-Based Independence for Seniors Act of 2019
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
PFIZER via LINCOLN POLICY GROUP
2020 · fourth_quarter · Q4
Issues related to drug pricing S.2543 - Prescription Drug Pricing Reduction Act of 2019 H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act Outreach regarding Rare Disease and Part-D copay assistance report language in FY2021 Labor HHS Appropriations cycle Outreach regarding drug supply concerns. COVID relief proposals Outreach on biosimilar shared savings.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
HUMACYTE, INC. via LINCOLN POLICY GROUP
2020 · fourth_quarter · Q4
Access to regenerative medical technologies.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS MEDICAL CARE NORTH AMERICA via LINCOLN POLICY GROUP
2020 · fourth_quarter · Q4
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities. COVID relief proposals Issues relating to Medicare Advantage proposed dialysis access policies
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities. COVID relief proposals Issues relating to Medicare Advantage proposed dialysis access policies
BUCHANAN, INGERSOLL, & ROONEY OBO STRATEGIC HEALTH INFO EXCHANGE COLLABORATIVE via LINCOLN POLICY GROUP
2020 · fourth_quarter · 4T
Issues related to health information exchanges and accompanying technologies supporting COVID-19 relief efforts and interoperability
Issues related to health information exchanges and accompanying technologies supporting COVID-19 relief efforts and interoperability
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERISOURCEBERGEN CORPORATION via LINCOLN POLICY GROUP
2020 · fourth_quarter · Q4
General healthcare issues S. 2543--Prescription Drug Pricing Reduction Act of 2019 COVID relief proposals
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
UPMC HEALTH PLAN via LINCOLN POLICY GROUP
2020 · third_quarter · Q3
Issues related to COVID; General issues related to Medicare and Medicaid; issues related to commercial insurance
Issues related to COVID; General issues related to Medicare and Medicaid; issues related to commercial insurance
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · third_quarter · Q3
Medical billing issues Medicare legislative and regulatory issues S.1895 - Lower Health Care Costs Act H.R.3630 - No Surprises Act COVID relief proposals
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SCAN HEALTH PLAN via LINCOLN POLICY GROUP
2020 · third_quarter · Q3
Medicare Advantage and SNP plans; Issues related to dual eligibles. H.R. 3461 Community-Based Independence for Seniors Act of 2019
Medicare Advantage and SNP plans; issues related to dual eligibles. H.R. 3461 Community-Based Independence for Seniors Act of 2019
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
PFIZER via LINCOLN POLICY GROUP
2020 · third_quarter · Q3
Issues related to drug pricing S.2543 - Prescription Drug Pricing Reduction Act of 2019 H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act Outreach regarding Rare Disease and Part-D copay assistance report language in FY2021 Labor HHS Appropriations cycle Outreach regarding drug supply concerns. COVID relief proposals Outreach on biosimilar shared savings.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
HUMACYTE, INC. via LINCOLN POLICY GROUP
2020 · third_quarter · Q3
Access to regenerative medical technologies.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS MEDICAL CARE NORTH AMERICA via LINCOLN POLICY GROUP
2020 · third_quarter · Q3
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities. COVID relief proposals Issues relating to Medicare Advantage proposed dialysis access policies
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities. COVID relief proposals Issues relating to Medicare Advantage proposed dialysis access policies
BUCHANAN, INGERSOLL, & ROONEY OBO STRATEGIC HEALTH INFO EXCHANGE COLLABORATIVE via LINCOLN POLICY GROUP
2020 · third_quarter · Q3
Issues related to health information exchanges and accompanying technologies supporting COVID-19 relief efforts and interoperability
Issues related to health information exchanges and accompanying technologies supporting COVID-19 relief efforts and interoperability
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERISOURCEBERGEN CORPORATION via LINCOLN POLICY GROUP
2020 · third_quarter · Q3
General healthcare issues S. 2543--Prescription Drug Pricing Reduction Act of 2019 COVID relief proposals
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BUCHANAN, INGERSOLL, & ROONEY OBO STRATEGIC HEALTH INFO EXCHANGE COLLABORATIVE via LINCOLN POLICY GROUP
2020 · third_quarter · RR
Issues related to health information exchanges and accompanying technologies supporting COVID-19 relief efforts and interoperability
Issues related to health information exchanges and accompanying technologies supporting COVID-19 relief efforts and interoperability
UPMC HEALTH PLAN via LINCOLN POLICY GROUP
2020 · second_quarter · Q2
Issues related to COVID; General issues related to Medicare and Medicaid; issues related to commercial insurance
Issues related to COVID; General issues related to Medicare and Medicaid; issues related to commercial insurance
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · second_quarter · Q2
Medical billing issues Medicare legislative and regulatory issues S.1895 - Lower Health Care Costs Act H.R.3630 - No Surprises Act Paycheck Protection Program and Healthcare Enhancement Act (CARES Act 2.0) (H.R. 266)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SCAN HEALTH PLAN via LINCOLN POLICY GROUP
2020 · second_quarter · Q2
Medicare Advantage and SNP plans; issues related to dual eligibles. H.R. 3461 Community-Based Independence for Seniors Act of 2019
Medicare Advantage and SNP plans; Issues related to dual eligibles. H.R. 3461 Community-Based Independence for Seniors Act of 2019
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
PFIZER via LINCOLN POLICY GROUP
2020 · second_quarter · Q2
Issues related to drug pricing S.2543 - Prescription Drug Pricing Reduction Act of 2019 H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act Outreach regarding Rare Disease and Part-D copay assistance report language in FY2021 Labor HHS Appropriations cycle Outreach regarding drug supply concerns. Paycheck Protection Program and Healthcare Enhancement Act (CARES Act 2.0) (H.R. 266) Outreach on biosimilar shared savings.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
HUMACYTE, INC. via LINCOLN POLICY GROUP
2020 · second_quarter · Q2
Access to regenerative medical technologies.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS MEDICAL CARE NORTH AMERICA via LINCOLN POLICY GROUP
2020 · second_quarter · Q2
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities. Paycheck Protection Program and Healthcare Enhancement Act (CARES Act 2.0) (H.R. 266) Issues relating to Medicare Advantage proposed dialysis access policies
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities. Paycheck Protection Program and Healthcare Enhancement Act (CARES Act 2.0) (H.R. 266) Issues relating to Medicare Advantage proposed dialysis access policies
AMERISOURCEBERGEN CORPORATION via LINCOLN POLICY GROUP
2020 · second_quarter · Q2
General healthcare issues S. 2543--Prescription Drug Pricing Reduction Act of 2019 Paycheck Protection Program and Healthcare Enhancement Act (CARES Act 2.0) (H.R. 266)
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
UPMC HEALTH PLAN via LINCOLN POLICY GROUP
2020 · second_quarter · RR
Issues related to COVID-19; issues related to Medicare and Medicaid; issues related to commercial insurance
Issues related to COVID-19; issues related to Medicare and Medicaid; issues related to commercial insurance
2020 · first_quarter · Q1
Medical billing issues Medicare legislative and regulatory issues S.1895 - Lower Health Care Costs Act H.R.3630 - No Surprises Act H.R. 748/S. 3548--CARES Act (Coronavirus Aid, Relief, and Economic Security Act) and covid-19 response
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SCAN HEALTH PLAN via LINCOLN POLICY GROUP
2020 · first_quarter · Q1
Medicare Advantage and SNP plans; Issues related to dual eligibles. H.R. 3461 Community-Based Independence for Seniors Act of 2019
Medicare Advantage and SNP plans; issues related to dual eligibles. H.R. 3461 Community-Based Independence for Seniors Act of 2019
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
PFIZER via LINCOLN POLICY GROUP
2020 · first_quarter · Q1
Issues related to drug pricing S.2543 - Prescription Drug Pricing Reduction Act of 2019 H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act Outreach regarding Rare Disease and Part-D copay assistance report language in FY2021 Labor HHS Appropriations cycle Outreach regarding drug supply concerns. Outreach regarding vaccine co-pay language in CARES Act (H.R. 748/S. 3548--Coronavirus Aid, Relief, and Economic Security Act) Outreach on biosimilar shared savings.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
HUMACYTE, INC. via LINCOLN POLICY GROUP
2020 · first_quarter · Q1
Access to regenerative medical technologies.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS MEDICAL CARE NORTH AMERICA via LINCOLN POLICY GROUP
2020 · first_quarter · Q1
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities. H.R. 748/S. 3548--CARES Act (Coronavirus Aid, Relief, and Economic Security Act) and covid-19 response Issues relating to Medicare Advantage proposed dialysis access policies
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities. H.R. 748/S. 3548--CARES Act (Coronavirus Aid, Relief, and Economic Security Act) and covid-19 response Issues relating to Medicare Advantage proposed dialysis access policies
AMERISOURCEBERGEN CORPORATION via LINCOLN POLICY GROUP
2020 · first_quarter · Q1
General healthcare issues S. 2543--Prescription Drug Pricing Reduction Act of 2019 H.R. 748/S. 3548--CARES Act (Coronavirus Aid, Relief, and Economic Security Act) and covid-19 response
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SCAN HEALTH PLAN via LINCOLN POLICY GROUP
2019 · fourth_quarter · 4A
Medicare Advantage and SNP plans; Issues related to dual eligibles. H.R. 3461 Community-Based Independence for Seniors Act of 2019
Medicare Advantage and SNP plans; issues related to dual eligibles. H.R. 3461 Community-Based Independence for Seniors Act of 2019
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
HUMACYTE, INC. via LINCOLN POLICY GROUP
2019 · fourth_quarter · 4A
Access to regenerative medical technologies.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS MEDICAL CARE NORTH AMERICA via LINCOLN POLICY GROUP
2019 · fourth_quarter · 4A
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities.
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2019 · fourth_quarter · Q4
Medical billing issues Medicare legislative and regulatory issues S.1895 - Lower Health Care Costs Act H.R.3630 - No Surprises Act
Filing targets: SENATE
SCAN HEALTH PLAN via LINCOLN POLICY GROUP
2019 · fourth_quarter · Q4
Medicare Advantage and SNP plans; issues related to dual eligibles. H.R. 3461 Community-Based Independence for Seniors Act of 2019
Medicare Advantage and SNP plans; Issues related to dual eligibles. H.R. 3461 Community-Based Independence for Seniors Act of 2019
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
PFIZER via LINCOLN POLICY GROUP
2019 · fourth_quarter · Q4
Issues related to drug pricing S.2543 - Prescription Drug Pricing Reduction Act of 2019 H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HUMACYTE, INC. via LINCOLN POLICY GROUP
2019 · fourth_quarter · Q4
Access to regenerative medical technologies.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS MEDICAL CARE NORTH AMERICA via LINCOLN POLICY GROUP
2019 · fourth_quarter · Q4
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities.
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
AMERISOURCEBERGEN CORPORATION via LINCOLN POLICY GROUP
2019 · fourth_quarter · Q4
General healthcare issues S. 2543--Prescription Drug Pricing Reduction Act of 2019
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS)
2019 · third_quarter · Q3
Medical billing issues Medicare legislative and regulatory issues
Filing targets: SENATE
SCAN HEALTH PLAN via LINCOLN POLICY GROUP
2019 · third_quarter · Q3
Medicare Advantage and SNP plans; Issues related to dual eligibles. H.R. 3461 Community-Based Independence for Seniors Act of 2019
Medicare Advantage and SNP plans; issues related to dual eligibles. H.R. 3461 Community-Based Independence for Seniors Act of 2019
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
PFIZER via LINCOLN POLICY GROUP
2019 · third_quarter · Q3
Issues related to drug pricing
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HUMACYTE, INC. via LINCOLN POLICY GROUP
2019 · third_quarter · Q3
Access to regenerative medical technologies, improvements in dialysis care.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS MEDICAL CARE NORTH AMERICA via LINCOLN POLICY GROUP
2019 · third_quarter · Q3
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities.
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
AMERISOURCEBERGEN CORPORATION via LINCOLN POLICY GROUP
2019 · third_quarter · Q3
General healthcare issues
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS)
2019 · third_quarter · RR
Medical billing issues Medicare legislative and regulatory issues
SCAN HEALTH PLAN via LINCOLN POLICY GROUP
2019 · second_quarter · 2A
Medicare Advantage and SNP plans; issues related to dual eligibles. H.R. 3461 Community-Based Independence for Seniors Act of 2019
Medicare Advantage and SNP plans; Issues related to dual eligibles. H.R. 3461 Community-Based Independence for Seniors Act of 2019
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
SCAN HEALTH PLAN via LINCOLN POLICY GROUP
2019 · second_quarter · Q2
Medicare Advantage and SNP plans; issues related to dual eligibles. S.309/H.R.4006 - Community-Based Independence for Seniors Act of 2017
Medicare Advantage and SNP plans; Issues related to dual eligibles. S.309/H.R.4006 - Community-Based Independence for Seniors Act of 2017
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
PFIZER via LINCOLN POLICY GROUP
2019 · second_quarter · Q2
Issues related to drug pricing
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HUMACYTE, INC. via LINCOLN POLICY GROUP
2019 · second_quarter · Q2
Access to regenerative medical technologies, improvements in dialysis care.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS MEDICAL CARE NORTH AMERICA via LINCOLN POLICY GROUP
2019 · second_quarter · Q2
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities.
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
AMERISOURCEBERGEN CORPORATION via LINCOLN POLICY GROUP
2019 · second_quarter · Q2
General healthcare issues
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS)
SCAN HEALTH PLAN via LINCOLN POLICY GROUP
2019 · first_quarter · Q1
Medicare Advantage and SNP plans; Issues related to dual eligibles. S.309/H.R.4006 - Community-Based Independence for Seniors Act of 2017
Medicare Advantage and SNP plans; issues related to dual eligibles. S.309/H.R.4006 - Community-Based Independence for Seniors Act of 2017
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
PFIZER via LINCOLN POLICY GROUP
2019 · first_quarter · Q1
Issues related to drug pricing
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KIDNEY CARE COUNCIL via LINCOLN POLICY GROUP
2019 · first_quarter · 1T
CMS Proposed Updates to Policies and Payment Rates for End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury (CMS 1674-P) Issues related to survey and certification of dialysis facilities under sub-regulatory guidance issued by the CMS Centers for Clinical Standards and Quality Issues related to charitable premium assistance for individuals with ESRD CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities; and issues related to sub-regulatory guidance affecting dialysis facility accreditation and dialysis care furnished in a skilled nursing facility.
CMS Proposed Updates to Policies and Payment Rates for End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury (CMS 1674-P) Issues related to survey and certification of dialysis facilities under sub-regulatory guidance issued by the CMS Centers for Clinical Standards and Quality Issues related to charitable premium assistance for individuals with ESRD CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities; and issues related to sub-regulatory guidance affecting dialysis facility accreditation and dialysis care furnished in a skilled nursing facility.
HUMACYTE, INC. via LINCOLN POLICY GROUP
2019 · first_quarter · Q1
Access to regenerative medical technologies, improvements in dialysis care.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS MEDICAL CARE NORTH AMERICA via LINCOLN POLICY GROUP
2019 · first_quarter · Q1
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities.
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
AMERISOURCEBERGEN CORPORATION via LINCOLN POLICY GROUP
2019 · first_quarter · Q1
General healthcare issues
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS)
AETNA, INC. via LINCOLN POLICY GROUP
2019 · first_quarter · 1T
Health care legislative and regulatory issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SCAN HEALTH PLAN via LINCOLN POLICY GROUP
2018 · fourth_quarter · Q4
Medicare Advantage and SNP plans; Issues related to dual eligibles. S.309/H.R.4006 - Community-Based Independence for Seniors Act of 2017
Medicare Advantage and SNP plans; issues related to dual eligibles. S.309/H.R.4006 - Community-Based Independence for Seniors Act of 2017
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
PFIZER via LINCOLN POLICY GROUP
2018 · fourth_quarter · Q4
Issues related to drug pricing
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KIDNEY CARE COUNCIL via LINCOLN POLICY GROUP
2018 · fourth_quarter · Q4
CMS Proposed Updates to Policies and Payment Rates for End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury (CMS 1674-P) Issues related to survey and certification of dialysis facilities under sub-regulatory guidance issued by the CMS Centers for Clinical Standards and Quality Issues related to charitable premium assistance for individuals with ESRD CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities; and issues related to sub-regulatory guidance affecting dialysis facility accreditation and dialysis care furnished in a skilled nursing facility.
CMS Proposed Updates to Policies and Payment Rates for End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury (CMS 1674-P) Issues related to survey and certification of dialysis facilities under sub-regulatory guidance issued by the CMS Centers for Clinical Standards and Quality Issues related to charitable premium assistance for individuals with ESRD CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities; and issues related to sub-regulatory guidance affecting dialysis facility accreditation and dialysis care furnished in a skilled nursing facility.
HUMACYTE, INC. via LINCOLN POLICY GROUP
2018 · fourth_quarter · Q4
Access to regenerative medical technologies, improvements in dialysis care.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS MEDICAL CARE NORTH AMERICA via LINCOLN POLICY GROUP
2018 · fourth_quarter · Q4
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities.
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
AMERISOURCEBERGEN CORPORATION via LINCOLN POLICY GROUP
2018 · fourth_quarter · Q4
General healthcare issues
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS)
AETNA, INC. via LINCOLN POLICY GROUP
2018 · fourth_quarter · Q4
Health care legislative and regulatory issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PFIZER via LINCOLN POLICY GROUP
2018 · fourth_quarter · RR
Issues related to drug pricing
AMERISOURCEBERGEN CORPORATION via LINCOLN POLICY GROUP
2018 · fourth_quarter · RR
General healthcare issues
SCAN HEALTH PLAN via LINCOLN POLICY GROUP
2018 · third_quarter · Q3
Medicare Advantage and SNP plans; issues related to dual eligibles.
Medicare Advantage and SNP plans; Issues related to dual eligibles.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
KIDNEY CARE COUNCIL via LINCOLN POLICY GROUP
2018 · third_quarter · Q3
CMS Proposed Updates to Policies and Payment Rates for End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury (CMS 1674-P) Issues related to survey and certification of dialysis facilities under sub-regulatory guidance issued by the CMS Centers for Clinical Standards and Quality Issues related to charitable premium assistance for individuals with ESRD CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities; and issues related to sub-regulatory guidance affecting dialysis facility accreditation and dialysis care furnished in a skilled nursing facility.
CMS Proposed Updates to Policies and Payment Rates for End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury (CMS 1674-P) Issues related to survey and certification of dialysis facilities under sub-regulatory guidance issued by the CMS Centers for Clinical Standards and Quality Issues related to charitable premium assistance for individuals with ESRD CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities; and issues related to sub-regulatory guidance affecting dialysis facility accreditation and dialysis care furnished in a skilled nursing facility.
HUMACYTE, INC. via LINCOLN POLICY GROUP
2018 · third_quarter · Q3
Access to regenerative medical technologies, improvements in dialysis care.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS MEDICAL CARE NORTH AMERICA via LINCOLN POLICY GROUP
2018 · third_quarter · Q3
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities.
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
AETNA, INC. via LINCOLN POLICY GROUP
2018 · third_quarter · Q3
Health care legislative and regulatory issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SCAN HEALTH PLAN via LINCOLN POLICY GROUP
2018 · second_quarter · Q2
Medicare Advantage and SNP plans; Issues related to dual eligibles.
Medicare Advantage and SNP plans; issues related to dual eligibles.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
KIDNEY CARE COUNCIL via LINCOLN POLICY GROUP
2018 · second_quarter · Q2
CMS Proposed Updates to Policies and Payment Rates for End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury (CMS 1674-P) Issues related to survey and certification of dialysis facilities under sub-regulatory guidance issued by the CMS Centers for Clinical Standards and Quality Issues related to charitable premium assistance for individuals with ESRD H.R. 3976, The Protecting Access to Marketplace Insurance Act of 2017 H.R. 5942 PATIENTs Act (114th Congress) S. 870, CHRONIC Act of 2017 H.R. 3178, Medicare Part B Improvement Act (includes H.R. 3166, dialysis facility accreditation legislation) of 2017 H.R. 2644, CKD Improvement in Research and Treatment Act of 2017
CMS Proposed Updates to Policies and Payment Rates for End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury (CMS 1674-P) Issues related to survey and certification of dialysis facilities under sub-regulatory guidance issued by the CMS Centers for Clinical Standards and Quality Issues related to charitable premium assistance for individuals with ESRD H.R. 3976, The Protecting Access to Marketplace Insurance Act of 2017 H.R. 5942 PATIENTs Act (114th Congress) S. 870, CHRONIC Act of 2017 H.R. 3178, Medicare Part B Improvement Act (includes H.R. 3166, dialysis facility accreditation legislation) of 2017 H.R. 2644, CKD Improvement in Research and Treatment Act of 2017
HUMACYTE, INC. via LINCOLN POLICY GROUP
2018 · second_quarter · Q2
Access to regenerative medical technologies, improvements in dialysis care.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS MEDICAL CARE NORTH AMERICA via LINCOLN POLICY GROUP
2018 · second_quarter · Q2
General health care regulatory work and advice
General health care regulatory work and advice.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
AETNA, INC. via LINCOLN POLICY GROUP
2018 · second_quarter · Q2
Health care legislative and regulatory issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE